Elyvia Biomedics GmbH

Elyvia is developing a next-generation diagnostic test for the early detection of ovarian cancer using only a drop of blood — no venipuncture, no central lab. The platform combines a self-calibrating biosensor with an AI-driven risk algorithm to deliver lab-grade accuracy in clinics, gynecology offices, or even at home

Elyvia Biomedics GmbH is a business in health.

Profile

Elyvia is developing a next-generation diagnostic test for the early detection of ovarian cancer using only a drop of blood — no venipuncture, no central lab. The platform combines a self-calibrating biosensor with an AI-driven risk algorithm to deliver lab-grade accuracy in clinics, gynecology offices, or even at home. By integrating multiple biomarkers with patient […]

The company sits in the health segment, where it competes on its core product or service.

It is recorded at the Creative Destruction Lab alumni company stage.

Website: www.elyvia.bio